Skip to content

A randomized placebo-controlled double-blind parallel-group trial on lipid metabolic effect of a food ingredient (G-PX)

A randomized placebo-controlled double-blind parallel-group trial on lipid metabolic effect of a food ingredient (G-PX) - An RCT (randomized controlled trial) on lipid metabolic effect of a food ingredient (G-PX)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033586
Enrollment
60
Registered
2018-08-01
Start date
2018-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adults

Interventions

carotenoid placebo

Sponsors

Ezaki Glico Co., Ltd.
Lead Sponsor
Tohoku University Graduate School of Agricultural Science / Faculty of Agriculyure
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Persons with relatively high oxidized LDL/LDL cholesterol (2) Persons with relatively high LDL cholesterol/HDL cholesterol (LH ratio) (3) Persons with BMI 30 or lower (4) Persons who can visit designated facilities on scheduled visiting dates (5) Persons who fully understood the purpose and content of the trial and gave written consent

Exclusion criteria

Exclusion criteria: (1) Persons who are receiving any treatment at the time of participation in the trial (2) Pregnant women (including those who are potentially pregnant) or lactating women (3) Smokers (4) Persons who made a blood component donation or whole blood donation of 200 mL within 4 weeks prior to the trial food intake (5) Persons who made a whole blood donation of 400 mL within 16 weeks prior to the trial food intake (6) Persons who underwent blood drawing of over 1000 mL within 48 weeks prior to the trial food intake (7) Persons who are participating in other trials or studies (8) Persons who meet any of the following: 1) Persons with heart, liver or kidney diseases (including complications of other diseases) 2) Persons with medical history of circulatory diseases 3) Persons with diabetes mellitus 4) Persons currently receiving treatment for or with medical history of serious diseases such as cancer or asthma (9) Persons with history of major surgery in the site of gastrointestinal tract such as gastrectomy, gastroenterostomy, or intestinal resection

Design outcomes

Primary

MeasureTime frame
To compare the amount of L/H ratio changes with placebo as a control

Countries

Japan

Contacts

Public ContactSatomi Nakano

edihas Co., Ltd. Division of Clinical Trial Support

nakano@edihas.co.jp0112527419

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026